Protection of ovarian function for female breast cancer patients undergoing chemotherapy / 中华内分泌外科杂志
Chinese Journal of Endocrine Surgery
; (6): 249-253, 2017.
Article
em Zh
| WPRIM
| ID: wpr-617284
Biblioteca responsável:
WPRO
ABSTRACT
Breast cancer is one of the most common malignant tumors in females.Recent years,surgery,chemotherapy as well as other systemic therapy had greatly improved the prognosis of the patients.However,damage of ovarian function by chemotherapy lowered life quality,especially for young females.At present,there are several methods to protect the ovarian function of female patients undergoing chemotherapy,such as administration of a gonadotropin-releasing hormone (GnRH) analogs,ovarian cryopreservation,unfertilized ova cryopreservation,embryo cryopreservation,inhibitors of apoptosis,etc.Each method has its advantage,disadvantage and indications.Issues related to ovarian protection are reviewed here.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Endocrine Surgery
Ano de publicação:
2017
Tipo de documento:
Article